clinical trials

News

First trial of Bundibugyo Ebola vaccine starts in UK

Oxford University has launched what it says is the world's first phase I trial of a vaccine specifically designed to protect against Bundibugyo Ebola.

News

Major trial launched to explore GLP-1 benefit in dementia

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

News

GSK to file Jemperli for rectal cancer after phase 3 readout

GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.

News

Bausch + Lomb drug fails in glaucoma, but a new use beckons

Bausch + Lomb has had a hole blown in its pharma pipeline, after disappointing trial results forced it to abandon BL117 for glaucoma.

News

Roche abandons two Huntington's drug candidates

Roche has scrapped two drugs for Huntington's disease – tominersen and RG6496 – after seeing disappointing results in clinical trials.

News

Keenova eyes Xiaflex as first drug for plantar fibromatosis

Keenova is hoping that its Xiaflex drug can become the first approved therapy for plantar fibromatosis, a debilitating condition affecting the feet.

First trial of Bundibugyo Ebola vaccine starts in UK

Major trial launched to explore GLP-1 benefit in dementia

GSK to file Jemperli for rectal cancer after phase 3 readout

Bausch + Lomb drug fails in glaucoma, but a new use beckons

Roche abandons two Huntington's drug candidates

Keenova eyes Xiaflex as first drug for plantar fibromatosis

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks